GlaxoSmithKline and Sanofi have both signed for a pharma alliances to work with the Bill & Melinda Gates Foundation.

The pharma alliance is to develop  new vaccine technologies under a newly devised Vaccine Discovery Partnership.

Glaxo will join the foundation in fronting $1.8 million for work on the thermostability of vaccines.

Sanofi Pasteur will work on an effort aimed at speeding up the development of new vaccines for emerging countries.

For further deal information visit Current Agreements (subscription required)

Related

Report: Partnering Deals and Alliances with GlaxoSmithKline

Report: Partnering Deals and Alliances with Sanofi

Browse: Complete Current Partnering report catalog

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter